Somanetics Corporation (Somanetics) has extended three-year agreement with Covidien Ltd. (Covidien). Covidien will continue to distribute Somanetics' INVOS Cerebral/Somatic Oximeter products in Europe, the Middle East and Africa. The extension would come into effect on February 16, 2010, on the expiry of the present agreement.

We are very pleased to extend this important relationship with Covidien under terms that both parties embrace, said Bruce Barrett, Somanetics’ president and chief executive officer.

Somanetics develops, manufactures and markets the In Vivo Optical Spectroscopy (INVOS) System.

Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.